Esperion Therapeutics Inc (ESPR) Q2 2020 Earnings Call Transcript

Esperion Therapeutics Inc (ESPR) Q2 2020 Earnings Call Transcript

With me on today's call are Tim Mayleben, President and Chief Executive Officer; Mark Glickman, Chief Commercial Officer; and Rick Bartram, Chief Financial Officer. Actual results could differ materially from those stated or implied by our forward-looking statements due to the risks and uncertainties associated with the business.